Literature DB >> 10710066

The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease.

Z Fireman1, A Osipov, S Kivity, Y Kopelman, A Sternberg, E Lazarov, E Fireman.   

Abstract

OBJECTIVE: Our aim was to evaluate lung involvement in Crohn's disease (CRD) patients by induced sputum (IS). Extraintestinal manifestations are frequent in CRD, but lung involvement is rare. Induced sputum is a reliable noninvasive method of investigating the pathogenesis, pathophysiology, and treatment of lung disease.
METHODS: Twenty-four CRD patients and nine control subjects (all nonsmokers) without respiratory symptoms were tested. Sputum was induced by 20' inhalation of 3.5% saline using ultrasonic nebulizer. Samples were studied by differential counts of 200 cells on cytopreps stained by Giemsa. T-lymphocyte subset analyses were done by FACS using three monoclonal antibodies: CD3 = total T cells, CD4 = T helper cells, and CD8 = T suppressor-cytotoxic cells. CD4/CD8 >2.5 was considered abnormal.
RESULTS: Four patients did not produce sputum. Of the remaining 20 patients, seven had active CRD and 13 were in remission. They were divided into two groups: Group A patients had abnormal CD4/CD8 ratio of 6.7 +/- 2.5; Group B (seven patients) had normal CD4/CD8 ratio of 1.7 +/- 0.52 (p = 0.0001). The differential counts of IS samples were similar in both groups, but lymphocyte count was significantly higher in CRD patients than in the control group (13.2 +/- 11.2 vs 4.8 +/- 3.6, p = 0.036). There were no differences in spirometry, treatment, extent, or activity of CRD.
CONCLUSION: Using a simple noninvasive method, we found that among CRD patients without respiratory symptoms there was a high (65%) incidence of lung involvement.

Entities:  

Mesh:

Year:  2000        PMID: 10710066     DOI: 10.1111/j.1572-0241.2000.01843.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects.

Authors:  Elizabeth Fireman; Yehuda Lerman; Moshe Stark; Asher Pardo; Yehuda Schwarz; Michael V Van Dyke; Jill Elliot; Briana Barkes; Lee Newman; Lisa Maier
Journal:  J Occup Environ Hyg       Date:  2014       Impact factor: 2.155

Review 2.  Patterns of airway involvement in inflammatory bowel diseases.

Authors:  Ilias Papanikolaou; Konstantinos Kagouridis; Spyros A Papiris
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 3.  Extraintestinal manifestations and complications in inflammatory bowel diseases.

Authors:  Katja S Rothfuss; Eduard F Stange; Klaus R Herrlinger
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 4.  Pulmonary manifestations of Crohn's disease.

Authors:  De-Gan Lu; Xiao-Qing Ji; Xun Liu; Hong-Jia Li; Cai-Qing Zhang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 5.  Neoplastic and other complications of inflammatory bowel disease.

Authors:  C N Bernstein
Journal:  Curr Gastroenterol Rep       Date:  2000-12

6.  Assessment of Occult Pulmonary Involvement in Ulcerative Colitis.

Authors:  Sudhir J Gupta; Vineet L Gupta; Harit G Kothari; Amol R Samarth; Nitin R Gaikwad; Sahil M Parmar
Journal:  Inflamm Intest Dis       Date:  2020-07-01

7.  Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases.

Authors:  E Fireman; Z Kraiem; O Sade; J Greif; Z Fireman
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

Review 8.  Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

Authors:  S Keely; N J Talley; P M Hansbro
Journal:  Mucosal Immunol       Date:  2011-11-16       Impact factor: 7.313

9.  Severe airway stenosis associated with Crohn's disease: case report.

Authors:  Maria Plataki; Eleni Tzortzaki; Irene Lambiri; Elpida Giannikaki; Armin Ernst; Nikolaos M Siafakas
Journal:  BMC Pulm Med       Date:  2006-04-07       Impact factor: 3.317

10.  Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis.

Authors:  Ioanna Tsiligianni; Katerina M Antoniou; Despina Kyriakou; Nikolaos Tzanakis; George Chrysofakis; Nikolaos M Siafakas; Demosthenes Bouros
Journal:  BMC Pulm Med       Date:  2005-06-24       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.